New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 29, 2014
07:46 EDTPCYCPharmacyclics upgraded to Outperform from Market Perform at Leerink
Leerink upgraded Pharmacyclics to Outperform citing increased expectations for Imbruvica in Chronic Lymphocytic Leukemia. After surveying 57 hematologists/oncologists, Leerink has an improved outlook for the drug. The firm raised its price target for shares to $142 from $102.
News For PCYC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 12, 2014
07:53 EDTPCYCLeerink to hold a tour
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use